Escalon Medical Corp. ESMC
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 12.74M | 11.45M | 12.31M | 11.94M | 12.05M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.74M | 11.45M | 12.31M | 11.94M | 12.05M |
| Cost of Revenue | 7.17M | 6.70M | 6.91M | 6.52M | 6.54M |
| Gross Profit | 5.57M | 4.75M | 5.40M | 5.42M | 5.51M |
| SG&A Expenses | 5.02M | 4.97M | 4.80M | 4.63M | 4.62M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.69M | 12.34M | 12.51M | 11.98M | 11.91M |
| Operating Income | 45.10K | -895.20K | -199.90K | -42.70K | 133.10K |
| Income Before Tax | 2.87M | 1.85M | -250.50K | -102.20K | 105.50K |
| Income Tax Expenses | -1.14M | -- | -- | -- | -- |
| Earnings from Continuing Operations | 4.01 | 1.85 | -0.25 | -0.10 | 0.11 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 4.01M | 1.85M | -250.50K | -102.20K | 105.50K |
| EBIT | 45.10K | -895.20K | -199.90K | -42.70K | 133.10K |
| EBITDA | 67.80K | -866.90K | -165.80K | -7.20K | 171.10K |
| EPS Basic | 0.25 | 0.11 | -0.04 | -0.03 | 0.00 |
| Normalized Basic EPS | 0.01 | -0.08 | -0.02 | -0.01 | 0.01 |
| EPS Diluted | 0.25 | 0.11 | -0.04 | -0.03 | 0.00 |
| Normalized Diluted EPS | -0.01 | -0.07 | -0.04 | -0.03 | -0.01 |
| Average Basic Shares Outstanding | 29.66M | 29.66M | 29.66M | 29.66M | 29.66M |
| Average Diluted Shares Outstanding | 51.20M | 43.76M | 43.42M | 43.08M | 43.08M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |